Gene expression of S100a8/a9 predicts Staphylococcus aureus-induced septic arthritis in mice
Frontiers in Microbiology · 15.06.2023 · 14
DOI: 10.3389/fmicb.2023.1146694 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 15.06.2023. Verfasst von Meghshree Deshmukh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Septic arthritis is the most aggressive joint disease associated with high morbidity and mortality. The interplay of the host immune system with the invading pathogens impacts the pathophysiology of septic arthritis. Early antibiotic treatment is crucial for a better prognosis to save the patients from severe bone damage and later joint dysfunction. To date, there are no specific predictive biomarkers for septic arthritis. Transcriptome sequencing analysis identified S100a8/a9 genes to be highly expressed in septic arthritis compared to non-septic arthritis at the early course of infection in an Staphylococcus aureus septic arthritis mouse model. Importantly, downregulation of S100a8/a9 mRNA expression at the early course of infection was noticed in mice infected with the S. aureus Sortase A/B mutant strain totally lacking arthritogenic capacity compared with the mice infected with parental S. aureus arthritogenic strain. The mice infected intra-articularly with the S. aureus arthritogenic strain significantly increased S100a8/a9 protein expression levels in joints over time. Intriguingly, the synthetic bacterial lipopeptide Pam2CSK4 was more potent than Pam3CSK4 in inducing S100a8/a9 release upon intra-articular injection of these lipopeptides into the mouse knee joints. Such an effect was dependent on the presence of monocytes/macrophages. In conclusion, S100a8/a9 gene expression may serve as a potential biomarker to predict septic arthritis, enabling the development of more effective treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States.
- Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
- Department of Rheumatology, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Zitieren
APA
Deshmukh, M., Subhash, S., Hu, Z., Mohammad, M., Jarneborn, A., Pullerits, R., Jin, T., & Kopparapu, P. K. (2023). Gene expression of S100a8/a9 predicts Staphylococcus aureus-induced septic arthritis in mice. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1146694
Vancouver
Deshmukh M, Subhash S, Hu Z, Mohammad M, Jarneborn A, Pullerits R, et al. Gene expression of S100a8/a9 predicts Staphylococcus aureus-induced septic arthritis in mice. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1146694
BibTeX
@article{Deshmukh2023,
author = {Deshmukh, Meghshree and Subhash, Santhilal and Hu, Zhicheng and Mohammad, Majd and Jarneborn, Anders and Pullerits, Rille and Jin, Tao and Kopparapu, Pradeep Kumar},
title = {Gene expression of S100a8/a9 predicts Staphylococcus aureus-induced septic arthritis in mice},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1146694}
}
EUVIMED